CN Patent

CN117964628A — 作为cdk9抑制剂的大环类化合物及其应用

Assigned to Kehui Zhiyao Biotechnology Shenzhen Co ltd · Expires 2024-05-03 · 2y expired

What this patent protects

本公开提供了式(I)化合物、其药物组合物及其在治疗和/或预防与CDK9激酶活性相关的疾病或病症中的应用。

USPTO Abstract

本公开提供了式(I)化合物、其药物组合物及其在治疗和/或预防与CDK9激酶活性相关的疾病或病症中的应用。

Drugs covered by this patent

pacritinib-citrate (PACRITINIB CITRATE)

Patent Metadata

Patent number: CN117964628A
Jurisdiction: CN
Classification: —
Expires: 2024-05-03
Drug substance claim: No
Drug product claim: No
Assignee: Kehui Zhiyao Biotechnology Shenzhen Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.